We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
-14.25%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$438B
AUM Growth
-$78.4B
Cap. Flow
+$5.92B
Cap. Flow %
1.35%
Top 10 Hldgs %
19.19%
Holding
4,820
New
167
Increased
1,786
Reduced
2,376
Closed
241

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$305M
2
TSLA icon
Tesla
TSLA
+$304M
3
XOM icon
ExxonMobil
XOM
+$277M
4
WBD icon
Warner Bros
WBD
+$263M
5
LIN icon
Linde
LIN
+$237M

Sector Composition

Rank Sector Weight
1 Technology 23.18%
2 Healthcare 14.61%
3 Financials 11.99%
4 Consumer Discretionary 9.25%
5 Industrials 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COCP icon
4326
Cocrystal Pharma
COCP
$15.2M
$18K ﹤0.01%
3,710
PEAR
4327
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$18K ﹤0.01%
11,899
+481
+4% +$1.88K
RUBY
4328
DELISTED
Rubius Therapeutics, Inc
RUBY
$18K ﹤0.01%
20,990
-126,267
-86% -$212K
AMPE
4329
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$18K ﹤0.01%
352
-1,469
-81% -$109K
BNTC icon
4330
Benitec Biopharma
BNTC
$431M
$17K ﹤0.01%
872
-6
-0.7% -$140
GRDX
4331
GridAI Technologies Corp
GRDX
$26.8M
$17K ﹤0.01%
7
AWH
4332
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$17K ﹤0.01%
1,909
-12,889
-87% -$131K
WTT
4333
DELISTED
Wireless Telecom Group, Inc.
WTT
$17K ﹤0.01%
12,982
-1,236
-9% -$1.86K
AAOI icon
4334
Applied Optoelectronics
AAOI
$11B
$16K ﹤0.01%
10,550
-305
-3% -$747
CBIO
4335
Crescent Biopharma
CBIO
$618M
$16K ﹤0.01%
262
-1
-0.4% -$74
RKTO
4336
Rocket One Inc
RKTO
$19.3M
$16K ﹤0.01%
1,545
-11
-0.7% -$140
PFIE
4337
DELISTED
Profire Energy, Inc
PFIE
$16K ﹤0.01%
10,997
TTOO
4338
DELISTED
T2 Biosystems, Inc
TTOO
$16K ﹤0.01%
20
RVLP
4339
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$16K ﹤0.01%
12,078
ATNX
4340
DELISTED
Athenex, Inc. Common Stock
ATNX
$16K ﹤0.01%
2,015
-11,885
-86% -$133K
MCHX icon
4341
Marchex
MCHX
$80.6M
$15K ﹤0.01%
11,245
NGNE icon
4342
Neurogene
NGNE
$713M
$15K ﹤0.01%
723
-5,078
-88% -$124K
OPTT icon
4343
Ocean Power Technologies
OPTT
$55.4M
$15K ﹤0.01%
25,818
SNES icon
4344
SenesTech
SNES
$6.78M
$15K ﹤0.01%
12
SNGX icon
4345
Soligenix
SNGX
$8.29M
$15K ﹤0.01%
108
TECX
4346
Tectonic Therapeutic
TECX
$664M
$15K ﹤0.01%
1,399
-10,724
-88% -$126K
ARAV
4347
DELISTED
Aravive, Inc. Common Stock
ARAV
$15K ﹤0.01%
15,144
-43,674
-74% -$57.6K
ACER
4348
DELISTED
Acer Therapeutics Inc
ACER
$14K ﹤0.01%
11,075
-58
-0.5% -$121
ALR
4349
DELISTED
AlerisLife Inc
ALR
$14K ﹤0.01%
11,437
-21,670
-65% -$35.2K
ALF
4350
DELISTED
ALFI Inc
ALF
$14K ﹤0.01%
11,918

Similar funds

Bank of New York Mellon's Q2 2022 Portfolio in Review

As of Q2 2022, Bank of New York Mellon held 4,820 positions worth $438B, down 15% from $516B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Bank of New York Mellon's Q2 2022 filing shows 167 new, 1,786 increased, 2,376 reduced and 241 closed positions. Its largest new stake was Hess Midstream: 1,736,004 shares worth $48.6M. The largest sale was Apple, an estimated $403M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2022 buy was Hess Midstream: 1,736,004 shares worth $48.6M.
  • Bank of New York Mellon added most to Goldman Sachs in Q2 2022, an estimated $305M increase.
  • Bank of New York Mellon's biggest Q2 2022 reduction was Apple, cutting an estimated $403M.
  • Bank of New York Mellon fully exited Cerner Corp in Q2 2022, selling an estimated $371M.
  • Bank of New York Mellon's ten largest holdings make up 19% of its $438B portfolio in Q2 2022.
  • Bank of New York Mellon opened 167 new positions and closed 241 in Q2 2022.
  • Bank of New York Mellon's portfolio value fell 15% quarter-over-quarter to $438B.

Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.